News

ORIC Pharmaceuticals to Showcase Innovations at Investor Events

ORIC Pharmaceuticals to Showcase Innovations at Investor Events

ORIC Pharmaceuticals' Engagement in Upcoming Conferences

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) is set to participate in several key investor conferences this September, where the company will have the opportunity to share its groundbreaking work in oncology. This clinical-stage biopharmaceutical company is committed to overcoming resistance in cancer treatment, developing therapies that significantly improve patient outcomes.

Conferences Scheduled for September

The management of ORIC Pharmaceuticals will take part in various investor conferences aimed at advancing dialogue with current and prospective investors. The details of the conferences are as follows:

Citi's 2025 Biopharma Back to School Summit

On September 3, 2025, ORIC Pharmaceuticals will participate in a fireside chat at 4:00 p.m. ET, alongside one-on-one meetings to offer more personalized interactions with investors.

2025 Wells Fargo Healthcare Conference

Following the Citi summit, the team will engage at the Wells Fargo Healthcare Conference on September 4, 2025, at 2:15 p.m. ET, providing more insights into their transformative approaches.

Cantor Global Healthcare Conference 2025

The conference line-up continues with the Cantor Global Healthcare Conference on September 5, 2025. There, ORIC will engage in discussions starting at 8:35 a.m. ET.

Morgan Stanley 23rd Annual Global Healthcare Conference

On September 9, 2025, the management will also hold one-on-one meetings, allowing investors to delve deeper into the company’s strategies and future directions.

Baird 2025 Global Healthcare Conference

The final event in this series is the Baird 2025 Global Healthcare Conference on September 10, 2025, at 1:25 p.m. ET, where management will again participate in a fireside chat.

Webcast Access and Future Availability

Investors who wish to catch up on these key discussions can find live webcasts through the investor section of the company's website. Replays of the events will remain available for 90 days post-conference, making it easy for stakeholders to stay updated.

About ORIC Pharmaceuticals, Inc.

ORIC is a pioneering biopharmaceutical entity focused on transforming cancer therapy through innovative treatments. Its principal products include ORIC-944, which targets mechanisms responsible for prostate cancer, and enozertinib (ORIC-114), a brain-penetrant inhibitor aimed at various genetically defined cancers. This dedicated research aims not just to treat, but also to effectively combat therapeutic resistance that challenges current treatments.

Company Contact Information

For inquiries, please contact:
Dominic Piscitelli, Chief Financial Officer
dominic.piscitelli@oricpharma.com
info@oricpharma.com

Frequently Asked Questions

What is the focus of ORIC Pharmaceuticals?

ORIC Pharmaceuticals focuses on developing innovative therapies that address mechanisms of resistance in cancer treatments.

When will ORIC Pharmaceuticals participate in investor conferences?

ORIC will participate in several investor conferences throughout September 2025.

How can I access the webcasts of the conference?

Live webcasts will be accessible through the investor section of ORIC's website, with replays available for 90 days.

What are the key product candidates of ORIC Pharmaceuticals?

The main product candidates include ORIC-944 and enozertinib (ORIC-114), which target mechanisms in various types of cancer.

How can I contact ORIC Pharmaceuticals for more information?

You can reach out via email to Dominic Piscitelli or the company’s general inquiries email for further information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ohio's Visionary Leadership Honored with Prestigious Award

Updated Category News Views 2

Award for Exceptional Vision Care Leadership Ain't every day you see a politician scooping up awards for making a real difference in folks' lives. Yet here we are, tipping our hats to Ohio's Governor Mike DeWine, who's just been dubbed the honcho with the golden eye for children's vision care in the 12th annual Bonnie Strickland Champion for Children's Vision Award. Hats...

Continue Reading
Allegra RMS Wins Big at Red Dot Award 2026

Updated Category News Views 2

Amid the hustle and bustle of the airport industry, AirportLabs is turning heads and grabbing awards. Their latest triumph? Allegra RMS taking home a Red Dot Award in the Digital Solutions category. Quite the feather in their cap, proving once again they’ve got a knack for navigating the skies of innovation. Breaking Tradition with Intuitive Design Airports have long...

Continue Reading
Beyoncé Drops Remastered 'B'DAY'; Celebrates Legacy

Updated Category News Views 1

Every so often, an artist comes around who's not just making music but shifting the very landscape of their genre. Beyoncé isn't just marking her birthday today; she's reminding the world of a career-defining moment with the release of her remastered deluxe version of 'B'DAY'. This isn't just a stroll down memory lane; it's a full-blown revival of an era that reshaped...

Continue Reading
Pentair Faces Class Action Over Fraud Allegations

Updated Category News Views 1

Catastrophe Strikes Pentair Ah, the sweet sound of a lawsuit hammering down on Wall Street—a routine part of corporate life for some of the biggest players in the game. This time, the bell tolls for Pentair plc, and it ain't pretty, folks. News just dropped that investors in New York Stock Exchange: PNR are staring down a newly expanded securities fraud class action...

Continue Reading
Long Island's JCC Boosted by Manes Family Legacy

Updated Category News Views 1

Unpacking a Monumental Gift to Long Island's Jewish Community Right out of the gate, this is a big one for the folks over at the Mid Island Y JCC in Plainview, Long Island. They've just hit the jackpot with a historic naming gift, transforming the place into the Manes JCC. Now, why does this matter to anyone keeping tabs on the nonprofit world? Because gifts like these...

Continue Reading
Graphic Packaging Names Berardinelli as HR Executive

Updated Category News Views 5

A New Chapter in HR Leadership at Graphic Packaging September 8 marks a turning point for Graphic Packaging Holding Company with the appointment of Tatiana Berardinelli as their new Chief Human Resources Officer. As NYSE:GPK positions itself for ambitious growth, Berardinelli stands out for her knack for managing transformations and building cultures that thrive in...

Continue Reading
ITP Media's Bold Move: Ready for Asian Market Surge

Updated Category News Views 4

Pushing Boundaries: ITP Media Group Eyes Asia ITP Media Group isn't here to tiptoe around the media market; they're diving headfirst with the recent takeover of Heart Media Group. A bold move, some might say, in this volatile world of media mergers and acquisitions. But let's break down what this really means. A Strategic Bet on Luxury To start, ITP Media is beefing up...

Continue Reading
Gan & Lee's Global Gamble: Europe Beckons with Menarini

Updated Category News Views 2

Shifting Gears: Gan & Lee's Major European Play Picture it—Asian biopharma juggernaut Gan & Lee Pharmaceuticals is hitching a ride with Europe's Menarini Group to take its flagship, bofanglutide, across the vast European market. It's a move that's got shades of grand ambition, colorful strategy, and not a small sum riding on its success. Cracking the Metabolic Code The...

Continue Reading
Mohegan Sun's Star-Studded 30th Year Bash: Details Inside

Updated Category News Views 5

Mohegan Sun Hits the Big 3-0 with a Bang When a casino decides to throw a party, you already know they spare no expense. Mohegan Sun's hitting the big thirty this October, and they've got a lineup that screams celebration. This isn’t just about a glossy red carpet or celebrity sightings, folks. It’s about a milestone that reflects years of stellar entertainment,...

Continue Reading
BRP's C-Suite Shakeup: What It Means for Investors

Updated Category News Views 2

Passing the Baton in BRP's Financial Helm Alright, folks, grab your coffee and listen up. There's a shakeup coming from the cold corners of Valcourt, Quebec—BRP Inc., the powersports behemoth on the TSX: DOO, has announced a changing of the guard in their finance department. Come October 1st, there's a planned power shift as Sébastien Martel steps down as CFO, passing...

Continue Reading

Top 5 Most Recently Viewed Articles

Mid-Cap Surge Signals Positive Market Trends for 2026

Updated Category News Views 230

Key Market Highlights The global equities market is experiencing a strong surge, showcasing a shift in leadership that extends beyond the traditional mega-cap technology industry. This rotation has been particularly evident with mid-cap stocks reaching record highs, a clear indication of improved market breadth and sector balance. Mid-caps have emerged as a favored choice...

Continue Reading
Ruder Finn Achieves Top Ranking Among PR Firms Once Again

Updated Category News Views 444

Ruder Finn Celebrates #2 Ranking on Observer's PR Power List In an exciting announcement, Ruder Finn, one of the leading independent communications and marketing agencies, has achieved the impressive feat of being ranked #2 on Observer's prestigious PR Power List. This recognition underscores the agency's success in the field and highlights its culturally relevant and...

Continue Reading
Visionary Copper and Gold Mines Secures Funding for Growth

Updated Category News Views 153

Exciting Developments at Visionary Copper and Gold Mines Inc. VANCOUVER, British Columbia — Visionary Copper and Gold Mines Inc. (the "Company" or "Visionary") (TSXV: VCG) (OTCQX: VCGMF) is thrilled to share news about its latest initiative, a non-brokered private placement expected to raise up to $3.0 million. The funds generated will significantly contribute to the...

Continue Reading
W. P. Carey Exceeds Expectations with $1.6 Billion in 2024

Updated Category News Views 240

W. P. Carey Reports Record Investment Volume for 2024 W. P. Carey Inc. (NYSE: WPC), a prominent real estate investment trust (REIT) involved in net leasing, has recently unveiled impressive investment achievements for 2024. The company recorded a total investment volume of about $1.6 billion, driven by a robust focus on high-quality assets. This significant figure...

Continue Reading
PleoPharma Makes Strides in Cannabis Withdrawal Treatment

Updated Category News Views 91

Positive Phase 2b Results for PleoPharma's Lead Drug PleoPharma, Inc., a clinical-stage company dedicated to addressing cannabis-related health challenges, has made impressive strides in its research efforts. The company recently shared the outcomes of its Phase 2b clinical trial for its primary drug candidate, PP-01, which is specifically designed to help alleviate...

Continue Reading